Trial Profile
A Randomized Placebo Controlled Trial of Duloxetine for Central Pain in Multiple Sclerosis.
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 13 Feb 2013
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary)
- Indications Central pain
- Focus Therapeutic Use
- 16 May 2011 Planned end date changed from 1 Apr 2011 to 1 Jun 2012 as reported by ClinicalTrials.gov.
- 18 May 2010 Eli Lilly added as trial sponsor and lead trial center as as reported by ClinicalTrials.gov.
- 18 May 2010 Planned end date changed from Apr 2009 to Apr 2011 as reported by ClinicalTrials.gov.